Publication | Closed Access

Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism

ThrombosisVenous ThrombosisMedicineMalignant Blood DisorderHematologyImmunologyPathologyCancer PatientsVenous ThromboembolismOncologyRadiation OncologyProtein C ResistanceTumor MicroenvironmentCancer ResearchHealth Sciences